Abstract:Roux-en Y gastric bypass (RYGB) surgery is among the most effective treatments for obesity, with the majority of weight lost as fat.Recent studies in humans and rats have demonstrated that RYGB alters gut microbial composition.Given the recently recognized link among diet, the gut microbiota, and host adiposity, we hypothesized that alterations in the gut microbiota after RYGB may contribute to the effects of this operation on the regulation of energy balance.16S rRNA pyrosequencing of bacterial DNA isolated from fecal samples revealed dramatic changes in gut microbial composition in diet-induced obese (DIO) mice that had undergone RYGB and were maintained on a 60% fat (kcal) diet, as compared to SHAM-operated (SO) animals maintained on the same diet.These effects occurred within one week after surgery and are characterized by multiple changes in microbial ecology, including a substantially increased prevalence of Proteobacteria.Weight loss induced by caloric restriction (weightmatched SO; WMS) did not show the same alterations in fecal microbiota as RYGB but were more similar to ad libitum fed SO animals, indicating that the observed changes in microbial ecology are specific to the surgical manipulation itself.Consistent with this conclusion, RYGB caused similar changes in the gut microbiota in non-obese animals maintained on a normal chow diet (14% fat; kcal).To assess the contribution of the RYGB-modified microbiota to the therapeutic effects of RYGB, we colonized germ free (GF) mice with cecal contents from either RYGB-treated or SO donor mice.GF recipients of SO donor cecal contents (SHAM-R) had 35% greater visceral adipose tissue than uninnoculated GF mice.In contrast, GF recipients of RYGB-treated donor cecal contents (RYGB-R) had 2% less visceral adipose tissue than the uninnoculated GF controls.The RYGB-R reconstituted mice had 27% less visceral adipose tissue than the SHAM-R reconstituted mice.RYGB-R mice also had 22% less visceral adipose tissue than GF mice colonized with cecal contents from WMS donors, suggesting that changes in gut microbial regulation of host adiposity after RYGB are independent of surgery-induced changes in body weight.These observations suggest that the alteration in microbial composition after RYGB contributes to the profound changes in energy balance and diminished adiposity induced by this operation.Elucidating the mechanisms by which altered gut microbiota exert these effects on host metabolic pathways will increase our understanding of the role of the gut on metabolic function more generally, revealing novel regulatory mechanisms that could be exploited to develop new, more effective nonsurgical therapies for obesity and related metabolic disorders.

The Family Coriobacteriaceae is a Potential Contributor to the Beneficial Effects of Roux-en-Y Gastric Bypass on Type 2 Diabetes

Roux-en-Y Gastric Bypass Improved Insulin Resistance Via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia

Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes

The genus Sutterella is a potential contributor to glucose metabolism improvement after Roux-en-Y gastric bypass surgery in T2D

Roux-en-Y gastric bypass-induced perturbative changes in microbial communities and metabolic pathways in rats

The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass

Changes of Serum Lipopolysaccharide, Inflammatory Factors, and Cecal Microbiota in Obese Rats with Type 2 Diabetes Induced by Roux-en-Y Gastric Bypass

Change in Gut Microbiota is Correlated with Alterations in the Surface Molecule Expression of Monocytes after Roux-en-Y Gastric Bypass Surgery in Obese Type 2 Diabetic Patients.

Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype

Gut microbiome modified by bariatric surgery improves insulin sensitivity and correlates with increased brown fat activity and energy expenditure

Roux-en-Y Gastric Bypass Surgery of Morbidly Obese Patients Induces Swift and Persistent Changes of the Individual Gut Microbiota

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass

Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways

Metabolomics Study of Roux-En-Y Gastric Bypass Surgery (rygb) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry

Chenodeoxycholic Acid As a Potential Prognostic Marker for Roux-en-Y Gastric Bypass in Chinese Obese Patients.

518 Patch Clamp Recordings Reveal Paracellular (tight Junction) Ion Channels

Effects of single-anastomosis duodenal–ileal bypass with sleeve gastrectomy on gut microbiota and glucose metabolism in rats with type 2 diabetes

Curative effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus and correlation analysis

Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission.

Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.

Alterations of DNA Methylation Profile in Proximal Jejunum Potentially Contribute to the Beneficial Effects of Gastric Bypass in a Diabetic Rat Model.